For instance, the expression of the coactivators CD40, CD80 and CD86, as well as the major histocompatibility complex (MHC) class I and II molecules, was found to be upregulated in mature DCs and macrophages by CDK4/6 inhibitors in different cancer models [110, 124]. This evidence concerns the gene HLA-C and cancer.